Back to Trials
NCT05343598NARecruiting

Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

Mclean Hospital

Start Date

10/13/2021

Completion Date

10/31/2026

Summary

This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study how hallucinations work in schizophrenia. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study the investigators will be stimulating the brain to learn more about how TMS might improve these symptoms of schizophrenia.

Detailed Description

This study tests the hypothesis that hallucinations in schizophrenia are mediated by network pathophysiology, and that network pathophysiology can be quantified by the functional connectivity of a cerebellar-thalamo-cortical circuit. To accomplish this, participants will be recruited who are diagnosed with schizophrenia or schizoaffective disorder who experience auditory hallucinations. Participants will undergo an initial screening session to complete informed consent and undergo baseline assessments of schizophrenia symptom severity. These assessments include reporter-based measures such as the Positive and Negative Syndrome Scale (PANSS). Participants will then undergo an MRI scan that includes structural and resting-state functional magnetic resonance imaging (rsfMRI). These rsfMRI imagines will be used to isolate individual resting state networks for targeting of rTMS modulation. Participants will then undergo five days of twice daily rTMS sessions. One week after the last rTMS session, participants will undergo follow-up MRI imaging and the same study assessments.

Eligibility Criteria

Age Range: 18 years to 55 years

Inclusion Criteria: * Diagnosis of schizophrenia or schizoaffective disorder Exclusion Criteria: * substance use disorder in past 3 months * ambidexterity * contraindications for TMS or MRI including : * history of neurological disorder * history of head trauma resulting in loss of consciousness * history of seizures or diagnosis of epilepsy or first degree relative family history of epilepsy * metal in brain or skull * implanted devices such as a pacemaker, medication pump, nerve stimulator or ventriculoperitoneal shunt * claustrophobic in MRI

Interventions

DEVICE

Repetitive Transcranial Magnetic Stimulation (rTMS)

DEVICE

Sham Repetitive Transcranial Magnetic Stimulation (rTMS)

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

SchizophreniaSchizo Affective Disorder

Locations

McLean Hospital

Belmont, Massachusetts 02478

United States